---
schema_version: "secwatch.filing_event.v1"
accession: "0001428336-23-000036"
form_type: "8-K"
ticker: "HQY"
cik: "0001428336"
company_name: "HEALTHEQUITY, INC."
filed_at: "2023-12-05T23:59:59+00:00"
generated_at: "2026-06-07T17:53:24.817698+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# HealthEquity Q3 revenue $249M (+15% YoY); net income $14.7M; acquires BenefitWallet HSA portfolio for ~$425M

## Summary
- Revenue $249.2M (+15% YoY); net income $14.7M vs net loss $1.6M prior year.
- Non-GAAP net income $52.2M (+61%); adjusted EBITDA $95.6M (+30%), margin 38%.
- HSAs 8.3M (+8%), total accounts 15.3M (+5%), HSA assets $22.6B (+12%).
- Agreed to acquire BenefitWallet HSA portfolio for ~$425M plus $20M expenses; ~$2.8B assets in 665k accounts; close H1 FY2025.
- FY2024 guidance: revenue $985-995M, adj. EBITDA $350-360M; FY2025 revenue ~$1.14-1.16B.

## SEC filing metadata
- accession: 0001428336-23-000036
- form_type: 8-K
- ticker: HQY
- cik: 0001428336
- company_name: HEALTHEQUITY, INC.
- filed_at: 2023-12-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000036/0001428336-23-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000036/hqy-20231205.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001428336-23-000036
- JSON: https://secwatch.observer/filing/0001428336-23-000036.json
- Plain text: https://secwatch.observer/filing/0001428336-23-000036.txt

## Key facts
- Earnings Releases
  HEALTHEQUITY, INC. reported third quarter ended October 31, 2023 results: revenue $249.2 million, net income $14.7 million, EPS $0.17 per diluted share.
  - Period: third quarter ended October 31, 2023
  - Revenue: $249.2 million
  - Net income: $14.7 million
  - EPS: $0.17 per diluted share
  - Result: reported results
  source text: in such a filing. --- EX-99.1 (EX-99.1) --- HealthEquity Reports Third Quarter Ended October 31, 2023 Financial Results Highlights of the third quarter include: • Revenue of $249.2 million, an increase of 15% compared to $216.1 million in Q3 FY23. • Net income of $14.7 million, compared to net loss of $1.6 million in Q3 FY23, with non-GAAP net income of $52.2
  evidence_url: https://www.sec.gov/Archives/edgar/data/1428336/000142833623000036/0001428336-23-000036-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.